Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 25.30
+1.16 (4.81%)
At close: Sep 30, 2026
SHA:688443 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 526.72 | 1,538 | 2,035 | 2,892 | 49.28 | 14.15 |
Trading Asset Securities | 1,332 | 681.23 | 412.58 | 27.71 | 237.36 | 427.11 |
Cash & Short-Term Investments | 1,858 | 2,219 | 2,448 | 2,920 | 286.64 | 441.25 |
Cash Growth | -22.26% | -9.36% | -16.16% | 918.65% | -35.04% | 684.19% |
Accounts Receivable | 86.59 | 21.08 | 12.01 | - | - | - |
Other Receivables | 0.01 | 0.06 | 1.38 | 0 | - | 1.53 |
Receivables | 86.6 | 21.14 | 13.38 | 0 | - | 1.53 |
Inventory | 140.46 | 96.12 | 50.15 | 55.45 | 56.33 | 33.66 |
Other Current Assets | 109.04 | 107.08 | 110.59 | 56.56 | 56.03 | 52.76 |
Total Current Assets | 2,194 | 2,443 | 2,622 | 3,032 | 399 | 529.2 |
Property, Plant & Equipment | 471.33 | 482.76 | 441.55 | 487.82 | 487.75 | 327.83 |
Other Intangible Assets | 45.4 | 42.69 | 43.59 | 43.54 | 45.08 | 45.92 |
Long-Term Deferred Charges | 20.9 | 20.17 | 25.16 | 27.92 | 25.51 | 23.51 |
Other Long-Term Assets | 7.07 | 4.41 | 13.26 | 3.46 | 4.77 | 76.36 |
Total Assets | 2,739 | 2,993 | 3,146 | 3,595 | 962.11 | 1,003 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 84.18 | 95.43 | 67.06 | 83.04 | 67.84 | 46.61 |
Accrued Expenses | 74.17 | 87.3 | 63.03 | 37.74 | 29.71 | 24.29 |
Short-Term Debt | 100.06 | - | - | 0.63 | - | - |
Current Portion of Long-Term Debt | 75.07 | 158.81 | 26.24 | - | 5.3 | 0.9 |
Current Portion of Leases | 10.02 | 11.07 | 12.13 | 10.07 | 7.64 | 6.51 |
Current Unearned Revenue | 46.74 | 114.52 | - | - | - | - |
Other Current Liabilities | 12.22 | 5.59 | 5.82 | 5.4 | 15.87 | 7.7 |
Total Current Liabilities | 402.47 | 472.72 | 174.29 | 136.87 | 126.37 | 86.01 |
Long-Term Debt | 942.65 | 884.82 | 786.13 | 608.48 | 738.59 | 535.55 |
Long-Term Leases | 5.35 | 7.98 | 12.63 | 21.82 | 30.37 | 28.65 |
Long-Term Unearned Revenue | 39.32 | 43.04 | 46.62 | 43.2 | 37.69 | 35.55 |
Other Long-Term Liabilities | 67.78 | - | - | - | - | 5.08 |
Total Liabilities | 1,458 | 1,409 | 1,020 | 810.36 | 933.03 | 690.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 366.68 | 366.68 | 366.68 | 366.68 | 275 | 275 |
Additional Paid-In Capital | 4,205 | 4,192 | 4,192 | 4,038 | 573.29 | 279.82 |
Retained Earnings | -3,270 | -2,953 | -2,418 | -1,621 | -819.21 | -242.84 |
Treasury Stock | -20.3 | -20.3 | -14.67 | - | - | - |
Shareholders' Equity | 1,282 | 1,585 | 2,126 | 2,784 | 29.08 | 311.98 |
Total Liabilities & Equity | 2,739 | 2,993 | 3,146 | 3,595 | 962.11 | 1,003 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,133 | 1,063 | 837.13 | 640.99 | 781.91 | 571.6 |
Net Cash (Debt) | 725.16 | 1,156 | 1,611 | 2,279 | -495.27 | -130.35 |
Net Cash Growth | -49.37% | -28.22% | -29.31% | - | - | - |
Net Cash Per Share | 1.97 | 3.15 | 4.38 | 7.11 | -1.80 | -0.47 |
Filing Date Shares Outstanding | 366.68 | 366.68 | 366.68 | 366.68 | 275 | 275 |
Total Common Shares Outstanding | 366.68 | 366.68 | 366.68 | 366.68 | 275 | 275 |
Working Capital | 1,792 | 1,971 | 2,448 | 2,895 | 272.63 | 443.19 |
Book Value Per Share | 3.50 | 4.32 | 5.80 | 7.59 | 0.11 | 1.13 |
Tangible Book Value | 1,236 | 1,542 | 2,082 | 2,741 | -15.99 | 266.06 |
Tangible Book Value Per Share | 3.37 | 4.21 | 5.68 | 7.47 | -0.06 | 0.97 |
Buildings | 115.11 | 115.11 | 115.03 | 114.98 | 105.89 | 99.77 |
Machinery | 571.37 | 529.02 | 516.53 | 457.63 | 302.65 | 261.93 |
Construction In Progress | 74.19 | 94.41 | 6.74 | 52.18 | 164.82 | 18.27 |